发明名称 |
Methods for assessing the suitability of transduced T cells for administration |
摘要 |
The invention relates to of analyzing vector supernatants useful for transducing T cells destined for administration to a human subject. The invention also related to methods of analyzing transduced T cells destined for administration to a human subject. |
申请公布号 |
US9572836(B2) |
申请公布日期 |
2017.02.21 |
申请号 |
US201314412844 |
申请日期 |
2013.07.12 |
申请人 |
The Trustees of the University of Pennsylvania |
发明人 |
June Carl H.;Levine Bruce L.;Kalos Michael D. |
分类号 |
C12Q1/04;A61K35/17;C12Q1/70;G01N33/569;G01N33/92;C07K16/28 |
主分类号 |
C12Q1/04 |
代理机构 |
Saul Ewing LLP |
代理人 |
Saul Ewing LLP ;Doyle Kathryn |
主权项 |
1. A method of analyzing a composition comprising a genetically modified T cell to detect a contaminant, the method comprises:
preparing the composition comprising the genetically modified T cell, wherein the genetically modified T cell comprises a nucleic acid encoding a chimeric antigen receptor (CAR) comprising an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a signaling domain; and analyzing the composition for at least one contaminant selected from the group consisting of a replication competent lentivirus (RCL), p24, a nucleic acid and/or protein derived from a plasmid used to package a lentivirus plasmid, vesicular stomatitis virus G-protein (VSV-G) nucleic acid and/or protein, and human immunodeficiency virus (HIV) gag. |
地址 |
Philadelphia PA US |